VINCERX PHARMA INC (VINC)

US92731L1061 - Common Stock

6.06  +0.94 (+18.36%)

Premarket: 6.15 +0.09 (+1.49%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to VINC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.18. This target is 51.49% above the current price.
VINC was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about VINC.
In the previous month the buy percentage consensus was at a similar level.
VINC was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 6.068.089.189.1810.50 - 33.33% 51.49% 51.49% 73.27%
Up and Down Grades
Date Firm Action Rating
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2022-11-17 Chardan Capital Maintains Buy
2022-08-12 SVB Leerink Maintains Outperform
2022-06-08 Cantor Fitzgerald Maintains Overweight
2022-06-07 Chardan Capital Maintains Buy
2022-06-07 B. Riley Securities Maintains Buy
2022-06-07 SVB Leerink Maintains Outperform
2022-05-13 Chardan Capital Maintains Buy
2022-05-13 SVB Leerink Maintains Outperform
2022-01-14 HC Wainwright & Co. Initiate Buy
2021-12-23 Cantor Fitzgerald Initiate Overweight
2021-11-01 SVB Leerink Initiate Outperform
2021-09-13 Laidlaw & Co. Initiate Buy
2021-08-25 B. Riley Securities Initiate Buy
2021-08-13 Chardan Capital Maintains Buy